NS
Natalie Scarritt
Vp Of Strategy And Marketing at Copyforward
View Natalie's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Sep 2021 - Present · 3 years and 3 months
Vp Of Strategy And Marketing
Mar 2023 - Present · 1 years and 9 months
Director Of Market Development
Sep 2021 - Apr 2023 · 1 years and 7 months
Naterra LLC
Founder And Consultant
Dec 2013 - Present · 11 years
Company Details
2-10 Employees
CopyForward is passionate about applying Web3 and the converging technologies to drive economic growth and transformation. CopyForward has created valuable intellectual property reflecting the vision for a Web3 ecosystem. CopyForward Inc. is an innovative technology company revolutionizing asset management through its groundbreaking technology. CopyForward’s state-of-the art technology fuses secure ledgers, Artificial Intelligence (AI), and the Internet of Things (IoT) to empower businesses to effectively handle physical, digital, intellectual, or real property having multiple encumbrances or obligations such as royalties, leases, liens, and loans in ways that are secure, immutable, unimpeachable, and efficient. CopyForward’s patent family enables organizations to efficiently manage assets with financial or non-financial obligations using Web3 technologies. This intellectual property has far-reaching applications across various sectors including gaming, non-fungible tokens (NFTs), fine art, music, sports, collectibles, real estate, finance, insurance, and manufacturing can unlock new revenue streams and enhance operational efficiency.
Year Founded
2021
Social Media
LinkedinTwitter
Industry
Software Development
HQ Location
150 Inverness Drive Winston Salem, NC 27107, US
Keywords
DeFiFintechArtCollectiblesAIIoTWeb3DLTSmartContractsDigital Assets
Discover More About Cleveland Clinic

Find verified contacts of Natalie Scarritt in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.